Global Rapid Sterility Testing Market Size, Share, Forecast Report, 2020-2027

Rapid Sterility Testing Market Scenario

Global Rapid Sterility Testing Market is expected to grow significantly over the forecast period. It is anticipated that the market held a market value of USD 158 million in 2017 and is projected to grow at a CAGR of 13.4% over the forecast period. Rapid sterility testing used to detect microbial contamination in given biologic sample. It is an alternative method for sterility testing.
The factors such as Increasing R&D expense and new product launches are expected to propel the growth of the market. However, availability of alternative traditional method hampers the market growth over the forecast period.

Rapid Sterility Testing Market Segmentation
The global rapid sterility testing market has been segmented into product, technology, and application.

Based on product, market segmented into kits & reagents, instruments, and services. The biological kits & reagents segment is expected to account for the largest share segment of the market in 2017.

Based on technology, has been segmented into membrane filtration, ATP bioluminescence, and other technologies.

Based on application, market segmented into pharmaceutical and biological manufacturing, medical device manufacturing, other end users.

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The rapid sterility testing market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European rapid sterility testing market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

The rapid sterility testing market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The rapid sterility testing market in the Middle East & Africa has been segmented into the Middle East and Africa.

Key Players

Charles River Laboratories, Inc. (US), Gibraltar Laboratories (US), Merck KGaA (Germany), Rapid Micro Biosystems, Inc. (US), bioMérieux (France), Eurofins Scientific (Luxembourg), Becton, Dickinson and Company (US), FOCUS Laboratories (US), Sartorius AG (Germany), and Thermo Fisher Scientific (US) are some of the key players in the global rapid sterility testing market.

Global Rapid Sterility Testing Market, by Product

• Kits & Reagents
• Instruments
• Services

Global Rapid Sterility Testing Market, by Technology

• Membrane Filtration
• ATP Bioluminescence
• Others

Global Rapid Sterility Testing Market, by Application

• Pharmaceutical and Biological Manufacturing
• Medical Device Manufacturing
• Others

Global Rapid Sterility Testing Market, by Region

• Americas
  • North America
    • US
    • Canada
  • South America

• Europe
  • Western Europe
    • Germany
    • France
    • Italy
    • Spain
    • UK
    • Rest of Western Europe
  • Eastern Europe

• Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific

• Middle East & Africa
  • Middle East
  • Africa

Global Rapid Sterility Testing Market, by Key Players

• Charles River Laboratories, Inc. (US)
• Merck KGaA (Germany)
• Rapid Micro Biosystems, Inc. (US)
• bioMérieux (France)
• Sartorius AG (Germany)
• Thermo Fisher Scientific (US)
• Eurofins Scientific (Luxembourg)
• Becton, Dickinson and Company (US)
• FOCUS Laboratories (US)
• Gibraltar Laboratories (US)

Intended Audience

• Rapid sterility testing Manufacturers and vendors
• Rapid sterility testing service providers
• Various research and consulting firms
• Pharmaceutical and Biotech companies
• Medical device companies